Even though numerous studies have reported that the ACE1 DD genotype is associated with COVID-19 severity, they are mostly limited to epidemiological studies and in silico analyses (Gómez et al., 2020; Pati et al., 2020; Verma et al., 2021). The gene discussed is ACE; the disease is COVID-19.